Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial (2021)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; OSORIO, FLAVIA DE LIMA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00213-020-05692-9
- Subjects: DEPRESSÃO; FARMACOTERAPIA; ALUCINOGÊNICOS; SUICÍDIO
- Keywords: Suicidality; Ayahuasca; Intervention; Major depressive disorder
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2021
- Source:
- Título: Psychopharmacology
- ISSN: 0033-3158
- Volume/Número/Paginação/Ano: v. 238, n. 2, p. 453-459, 2021
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
ZEIFMAN, Richard J. et al. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial. Psychopharmacology, v. 238, n. 2, p. 453-459, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00213-020-05692-9. Acesso em: 01 abr. 2026. -
APA
Zeifman, R. J., Singhal, N., Santos, R. G. dos, Sanches, R. F., Osório, F. de L., Hallak, J. E. C., & Weissman, C. R. (2021). Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial. Psychopharmacology, 238( 2), 453-459. doi:10.1007/s00213-020-05692-9 -
NLM
Zeifman RJ, Singhal N, Santos RG dos, Sanches RF, Osório F de L, Hallak JEC, Weissman CR. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial [Internet]. Psychopharmacology. 2021 ; 238( 2): 453-459.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1007/s00213-020-05692-9 -
Vancouver
Zeifman RJ, Singhal N, Santos RG dos, Sanches RF, Osório F de L, Hallak JEC, Weissman CR. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial [Internet]. Psychopharmacology. 2021 ; 238( 2): 453-459.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1007/s00213-020-05692-9 - Psychedelic medicines in major depression: progress and future challenges
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]
- Hallucinations and hallucinogens: psychopathology or wisdom?
- Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences
- Ayahuasca-enhanced extinction of fear behaviour: role ofinfralimbic cortex 5-HT 2A and 5-HT 1A receptors
- Psychedelics in psychiatry
- Acute psychological adverse reactions in first-time ritual ayahuasca users: a prospective case series
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Effects of ayahuasca on mental health and quality of life in naïve users: a longitudinal and cross-sectional study combination
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003187433.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
